image of Allison Tam
  • Telehealth Visits
bch logo

Allison Tam, MD

Medical Genetics and Genomics
Pediatric Medical Genetics Oakland
877-822-4453
image of Allison Tam
image of Allison Tam
bch logo

Allison Tam, MD

Medical Genetics and Genomics
Pediatric Medical Genetics Oakland
877-822-4453
  • Telehealth Visits

On this page

About me

Dr. Allison Tam is a medical genetics specialist who cares for patients with suspected or confirmed hereditary disorders. She sees children and adults for conditions including multiple abnormalities present at birth, hearing loss, abnormal growths, developmental delays, intellectual disabilities, autism spectrum disorders and family histories of a genetic condition.

Tam earned her medical degree at the John A. Burns School of Medicine at the University of Hawai'i at Mānoa. She completed a combined residency in pediatrics and medical genetics at Baylor College of Medicine.

Tam is a member of the American Academy of Pediatrics and American College of Medical Genetics and Genomics.

Education

Board Certification

  • Clinical Genetics and Genomics, American Board of Medical Genetics and Genomics
  • Pediatrics, American Board of Pediatrics

Residency

  • Pediatrics, Baylor College of Medicine
  • Medical Genetics, Baylor College of Medicine

Internship

  • Pediatrics, Baylor College of Medicine

School

  • MD, University of Hawaii School of Medicine

Academic Title

  • Health Sciences Clinical Professor

Care Keywords

  • Services
    • Medical Genetics and Genomics

Locations

    Provider Research Listing

    Browse clinical trials and publications by this provider

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.